Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date HCP Analysis in Biopharmaceuticals by Mass Spectrometry Annu Uppal PHD. at USP & Anita Krishnan at Biocon Biologics HCP Analysis in Biopharmaceuticals by Mass Spectrometry Best Practices for HCP Analysis in Biopharmaceuticals by Mass Spectrometry Presented by Annu ... January 4, 2024 8:30am In Depth Characterization with Mass Spectrometry and Orthogonal Methods of... Bruno Genet, Lab head Structural Analysis MS at Sanofi Full Title: In Depth Characterization with Mass Spectrometry and Orthogonal Methods of Conformers in a Trispecific HIV Antibody Presented by Bruno Ge... 3 years ago | 33 mins Identification of unknown extractables and leachables using mass spectrometry... Petra Booij, Investigator at GlaxoSmithKline & Dr Kyle D’Silva, Pharma & BioPharma Marketing Leader, Thermo Fisher Scientific Full Title: Identification of unknown extractables and leachables using mass spectrometry: Identification with confidence? Extractable and Leachable ... 3 years ago | 57 mins Host Cell Protein Characterisation and Mass Spectrometry Strategies Xuezhi Bi, Group Leader (Proteomics) /Senior Scientist, Bioprocessing Technology Institute, A*STAR Adding Mass Spectrometry as part of the host cell protein workflow Analytical Strategies in HCP identification and purification process Developing Qua... 5 years ago | 37 mins Advances in Mass Spectrometry for the Analysis and Bioanalysis of Antibody-Drug Arnaud Delobel, PhD ADCs are complex compounds resulting from the coupling of cytotoxic small molecules to a monoclonal antibody. Their characterization as well as their ... 6 years ago | 34 mins MALDI-TOF in the Clinical Lab: Effectiveness and Challenges Elizabeth Palavecino, M.D. Antimicrobial resistance is rising, prompting clinical laboratories to find effective solutions for fast, accurate microorganism identification. MALDI... 4 years ago | 65 mins Understanding the Propensity of Sequence Variants During Cell Line & Culture... Dr. Lisa Marzilli, Associate Research Fellow and group leader Mass Spectrometry at Pfizer, USA Sequence variants (SVs) are protein isoforms that contain one or more unintended amino acid substitutions. They can arise at a single amino acid site ... 5 years ago | 40 mins Advancing AML Biomarker Discovery with Multi-omic Analysis Alexis L. Santana, PhD - Champions Oncology & Guanghui Han, PhD - BGI San Jose Mass Spectrometry Center Champions Oncology is illuminating the cellular dynamics of cancer by using our revolutionary Lumin Bioinformatics Platform to re-discover your data. ... 2 years ago | 48 mins Identification of unknown extractables and leachables using mass spectrometry... Petra Booij, Investigator at GlaxoSmithKline & Dr Kyle D’Silva, Pharma & BioPharma Marketing Leader, Thermo Fisher Scientific Full Title: Identification of unknown extractables and leachables using mass spectrometry: Identification with confidence? Extractable and Leachable ... 4 years ago | 58 mins Monitoring Impurities in Biologics Diane McCarthy, PhD, Senior Scientific Liaison, Global Biologics, US Pharmacopeia The complexity of biotherapeutic products and their manufacturing processes can yield a variety of impurities, which must be monitored and controlled ... 3 years ago | 59 mins